Effect of Discontinuation of Sugar Sweetened Beverages

NCT ID: NCT00585897

Last Updated: 2015-10-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose The purpose of this study is to investigate the effects of discontinuation of sugar sweetened beverages on hemoglobin A1c (HbA1c) and plasma fasting and post-prandial blood glucose in a population with type 2 diabetes.

Hypothesis Elimination of sugar sweetened beverages from the diet for a 4 week period will lead to a decrease in HbA1c and plasma fasting and 2 hour post prandial blood glucose in a population with a history of type 2 diabetes and high consumption of sugar sweetened beverages.

Specific aims to test hypothesis

1. Investigate how elimination of sugar sweetened beverages from the diet affects HbA1c and plasma fasting and two hour post prandial blood glucose.
2. Test the feasibility of carrying out a simple diet intervention in an outpatient population with type 2 diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Type and Design of Study This will be a pilot study including adult patients age \>/= 18 diagnosed with Type 2 Diabetes who are patients at the Duke Outpatient Clinic (DOC) or patients in the general medicine or family practice clinics in Durham County. The intervention will be elimination of sugar sweetened beverages from the diet in a population of type 2 diabetic subjects for four weeks. Sugar sweetened beverages will be defined as any liquid beverage containing calories that can be attributed to natural or added sugar. This will not include beverages that contain mainly artificial sweeteners (e.g.: NutraSweet®, saccharin, Splenda®, or Equal®), plain milk, or water.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Behavioral counseling

Individual sessions which utilize motivational interviewing to assist participants to discontinue sugar sweetened beverages from their diet.

Group Type EXPERIMENTAL

discontinuation of sugar sweetened beverages

Intervention Type BEHAVIORAL

Individual sessions which utilize motivational interviewing to assist participants to eliminate sugar sweetened beverages from their diet.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

discontinuation of sugar sweetened beverages

Individual sessions which utilize motivational interviewing to assist participants to eliminate sugar sweetened beverages from their diet.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Prior diagnosis of Type 2 Diabetes for at least 1 year based on one of the following:

* Fasting blood glucose \>126 on two separate occasions
* Random blood glucose \>200 with symptoms
* Abnormal 75 or 100 gram Oral Glucose Tolerance Test (OGTT) defined as: fasting blood glucose \>100, 2hour post prandial blood sugar of \>140
* On medications for diabetes (oral or insulin)
2. Age \>/=18
3. Stable but uncontrolled blood glucose (Hemoglobin A1C \>7%, \</= 12%)
4. Ingestion of at least three eight ounce servings of sugar sweetened beverage daily.
5. Stable solid diet and exercise pattern and agreement not to change these during the study
6. Able and willing to maintain a complete diet diary for three days each week of the study (total of 12 days of recording)
7. Able to attend regular study visits
8. Able to give informed consent
9. Working phone number in order to contact patient
10. Able and willing to understand and comply with the intervention

Exclusion Criteria

1. Women who are known to be pregnant at enrollment based on a positive pregnancy test. Pregnancy test will be given to all female subjects of child bearing age prior to enrollment in the study. Pregnant women will be excluded on the basis that blood glucose data are significantly affected by the physiology of pregnancy. This exclusion is not based on any potential risk to the pregnant women or fetus.
2. Individuals \<18 years of age
3. Diagnosis of Type 1 Diabetes
4. Malabsorbtive syndrome of any type (will be determined based on medical history from patient and/or medical chart)
5. On Acarbose prior to start of study
6. On a weight loss diet within one month of enrollment
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bryan C. Batch, M.D.

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke University Medical Center

Durham, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Apovian CM. Sugar-sweetened soft drinks, obesity, and type 2 diabetes. JAMA. 2004 Aug 25;292(8):978-9. doi: 10.1001/jama.292.8.978. No abstract available.

Reference Type BACKGROUND
PMID: 15328331 (View on PubMed)

Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004 Aug 25;292(8):927-34. doi: 10.1001/jama.292.8.927.

Reference Type BACKGROUND
PMID: 15328324 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00010382

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Zinc on Glucose Homeostasis
NCT05835037 RECRUITING PHASE4
The Breakfast Study
NCT05986097 COMPLETED PHASE1/PHASE2
Pre-meal Protein Drink Improve Glycemic Regulation
NCT01987674 TERMINATED PHASE1/PHASE2